{"entity":{"type":"insider","cik":"0001566175","url":"/insider/0001566175","json_url":"/insider/0001566175.json","name":"SETH SANDESH","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":10,"first":"2015-12-16","last":"2018-12-10","span_basis":"filed_date"},"name_variants":[{"name":"SETH SANDESH","source":"filing","n_filings":10,"first_seen":"2015-12-16","last_seen":"2018-12-10"}],"transactions":[{"id":6561097,"accession":"0001213900-18-017145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-017145","line_url":"/filing/0001213900-18-017145#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4372,"price_display":"0.44","price_state":"stated","total_value":4372.0,"total_display":"4,372.00","total_whole":"4,372","shares_owned_after":153333.0,"shares_owned_after_display":"153,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-10","scope":"insider"},{"id":6080717,"accession":"0001213900-18-009317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-009317","line_url":"/filing/0001213900-18-009317#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.79,"price_display":"0.79","price_state":"stated","total_value":7900.0,"total_display":"7,900.00","total_whole":"7,900","shares_owned_after":143333.0,"shares_owned_after_display":"143,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-17","filed_date":"2018-07-17","scope":"insider"},{"id":6766344,"accession":"0001213900-18-004773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-004773","line_url":"/filing/0001213900-18-004773#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","total_whole":"1,900","shares_owned_after":133333.0,"shares_owned_after_display":"133,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-19","filed_date":"2018-04-20","scope":"insider"},{"id":4874350,"accession":"0001213900-17-008254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-008254","line_url":"/filing/0001213900-17-008254#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33333.0,"shares_display":"33,333","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":24999.75,"total_display":"24,999.75","total_whole":"25,000","shares_owned_after":75833.0,"shares_owned_after_display":"75,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"},{"id":4543457,"accession":"0001213900-17-006529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-17-006529","line_url":"/filing/0001213900-17-006529","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":1.1633333333333333,"price_display":"1.16","price_state":"stated","total_value":8725.0,"total_display":"8,725.00","total_whole":"8,725","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-15","filed_date":"2017-06-15","scope":"insider","n_lines":2},{"id":4572970,"accession":"0001213900-17-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-000008","line_url":"/filing/0001213900-17-000008#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":4400.0,"total_display":"4,400.00","total_whole":"4,400","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-30","filed_date":"2017-01-03","scope":"insider"},{"id":2559451,"accession":"0001213900-16-019329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-019329","line_url":"/filing/0001213900-16-019329#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":4900.0,"total_display":"4,900.00","total_whole":"4,900","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-12","filed_date":"2016-12-12","scope":"insider"},{"id":2257493,"accession":"0001213900-16-012633","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-16-012633","line_url":"/filing/0001213900-16-012633","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":1.9823076923076923,"price_display":"1.98","price_state":"stated","total_value":12885.0,"total_display":"12,885.00","total_whole":"12,885","shares_owned_after":23500.0,"shares_owned_after_display":"23,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-18","scope":"insider","n_lines":2},{"id":2257488,"accession":"0001213900-16-012633","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-16-012633","line_url":"/filing/0001213900-16-012633","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":2.0042857142857144,"price_display":"2.00","price_state":"stated","total_value":7015.0,"total_display":"7,015.00","total_whole":"7,015","shares_owned_after":17000.0,"shares_owned_after_display":"17,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-18","scope":"insider","n_lines":2},{"id":2257483,"accession":"0001213900-16-012633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-012633","line_url":"/filing/0001213900-16-012633#line-1","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-18","scope":"insider"},{"id":8805119,"accession":"0001213900-15-009538","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-15-009538","line_url":"/filing/0001213900-15-009538","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":3.1908421052631577,"price_display":"3.19","price_state":"stated","total_value":30313.0,"total_display":"30,313.00","total_whole":"30,313","shares_owned_after":120758.0,"shares_owned_after_display":"120,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider","n_lines":5},{"id":8606407,"accession":"0001213900-15-009524","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001213900-15-009524","line_url":"/filing/0001213900-15-009524","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001566175","owner_name":"SETH SANDESH","owner_display_name":"SETH SANDESH","owner_url":"/insider/0001566175","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10500.0,"shares_display":"10,500","price_per_share":2.9265142857142856,"price_display":"2.93","price_state":"stated","total_value":30728.4,"total_display":"30,728.40","total_whole":"30,728","shares_owned_after":112258.0,"shares_owned_after_display":"112,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-16","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":25,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001388320","name":"Actinium Pharmaceuticals, Inc.","url":"/issuer/0001388320","role":"Director, Officer (Chairman & CEO), Other","n_filings":8,"first_seen":"2016-04-18","last_seen":"2018-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001553643","name":"RELMADA THERAPEUTICS, INC.","url":"/issuer/0001553643","role":"Director","n_filings":2,"first_seen":"2015-12-16","last_seen":"2015-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001566175","retrieved_at":"2026-08-27T05:17:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}